It is without doubt going higher from where I sit but to buy here is risky so it would be a better buy once the technicals revert to a more neutral level.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025